Close
Smartlab Europe
Achema middle east

News

Modafinil In Focus: Understanding The Pros And Cons Of This Emerging Nootropic

In recent years, the world has witnessed an ever-growing interest in nootropics, compounds designed to enhance cognitive functions, with an increasing number of people choosing to buy nootropics from CosmicNootropic or similar reputable companies. Modafinil has risen as a...

Why Memory Care Provision Matters

Memory care is an essential consideration after receiving a related diagnosis. Navigating life after finding out you have dementia, for instance, can be scary, but it is made that much easier when you know what support is out there....

Plastics And Composites Reshaping Drug Packaging In China

As of the conclusion of 2018, Zenopa's report reveals that the Chinese pharmaceutical packaging sector boasted an astonishing 106.8 billion yuan in value. What's particularly striking is the noteworthy change in the materials employed for drug packaging, with plastic...

Key Steps For Biopharma Startups Getting Ready For EU HTA

What is the Joint European HTA? Navigating pricing and reimbursement in the European Union (EU) can be a complex task for emerging biopharmaceutical companies (EBPs), defined as those with less than $200 million in estimated annual R&D spending or global...

The Future of Pharma Traceability In Healthcare Packaging

The pharmaceutical sector, due to its importance in human health, is subject to rigorous global regulations. Pharmaceutical traceability, commonly known in the industry as pharma traceability, is employed to monitor the movement of pharmaceutical products within the supply chain. Healthcare...

Pharma Industry Response To DSCSA EDDS Stabilization Period

The HDA Traceability Seminar commenced with a full audience and a prevailing message woven into the presentations: The FDA's release of the DSCSA EDDS guidance on Friday, August 25th, should not be seen merely as a period of enforcement...

FDA Grants Pharmacies Extra Year For Security Compliance

The implementation of the Drug Supply Chain Security Act has been postponed until November 2024, granting pharmacies an additional year to prepare for compliance with the law's drug distribution security requirements. Originally passed in 2013, the full enforcement was...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »